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T his stud y suggests that cross-reactive tUJ11 o r-assoc iated 
an tigens (T AA) arc indu ced in the epidermis o f mice ex-
posed to su bca rcinogen ic doses of ul trJ vio let rad iJ tio n 
(UVR). Foot-pad immuniza tio n o f C3 H mice w ith viable 
epi derm al ce lls fro lll syngeneic UVn.-ex posed mi ce in-
duced cy totoxic cells in the drainin g lymph nodes (O LN ). 
T hese cells we re ca pable of lys in g a bJ ttery o f UVn-in-
d Ll ced tLlmo r tJrgets in a sho rt-term chromium relcJse as-
say. In contras t, the DLN ce ll s o f mi ce imlllunized with 
epidermal cells fro m norm al non-UVR-ex posed mi ce did 
no t m Jture into effecto r cell s w ith antitum o r acti vity. The 
spectrum of tLlm o r recognitio n of cytotox ic cell s in duced 
by immuniza tio n w ith UVR-ex posed epiderm al cell s was 
identi ca l to that of cy to toxic T cell s obtain ed fro m anilll ais 
that were foot-pad immunized w ith UVR-indu ced tum o r 
C hro ni c expos ure to ultrav io let rad ia ti o n (UV R) in th e 290-320 nm ra ll ge (s ho rt-wave UVB) has been show ll to have direc t and indirect detriJll. ental effects O il normal cutaneous processes. D irect effects o f UVR expos ure axe m ani fes t b y the fo ll owin g : pre m ature 
chan ges in the skin s imila r to those ca used by th e ag in g process 
II ,2L alte rat io ns in th e antigen-p resentin g capacity of Langerh ans 
cells /3 1. and the in d uction an d p ro m o ti o n of ce rta in sk in ca nccrs 
in both hum ans 14,51 and anim als 16,71. In d irec t effects at both 
low- an d hi g h-dosc ex pos ures to UVR have bcen show n to be 
capa bl e of abrogatin g ce rtain systc mi c immunc responses, such 
as de layed h ypersensiti vity to haptcns and o th er protei n antigens 
IS,9 1 an d th e abilit y to rejec t hi g hl y immunogeni c skin tum o rs 
11 0, 11 1. T he re la t io nship between th e direct effec ts o fUVR o n 
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A bbrcv iatio ns: 
C LN: co ntro l lymph nodc(s) 
cell s. Bo th cy totox ic ce ll po pulatio ns were shown to lyse 
tum o rs of di ve rse o ri gin , including syngeneic uvn- an d 
lll eth ylcho lanthrene-indLl ced tUlll o rs, as well as all ogeneic 
UVR-induced tumo rs. These cells displa yed mini!11allytic 
acti vity agJ in st Y AC-l lymph o lll J ce ll s, peri to neal exuda te 
cells, Jnd concJnJva lin A-stimulated splenocy tes. The re-
sults fro m thi s stud y demo nstrate that antigens are ex-
pressed on UVR-exposed m ouse epiderm al cells prio r to 
the emergence o f skin tum o rs, and th ese Jntigen s can in-
du ce cyto tox ic cells w ith spec ific ity fo r TAA . We conclude 
th ;! t the ea rl y anti genic changes o bse rved in UVR-ex posed 
epidermis and their effec t o n the hos t's immune sys tem 
may inAuence the emergence and progress io n o f UVR-
in d uced sk in ca ncers. J hllJcs/ Denl/n/o/ 88: 154-1 60, 1987 
exposed skin and sys temi c ch anges in immuno logic po tenti al is 
clea rl y co mpl ex. Thi s is es pecia ll y true considerin g th at o nly a 
s m all percentage of UV13 energy reaches th e d ermi s and ca pill ary 
beds, the m aj o ri ty bein g absorbed in pi g m en ted s t[:Hum corneUlll 
and th e nucle i of the m alpi g h ia n b yer 11 21. 
Since superfic ia l absorptio n of UV B energy occurs m ainl y w ithin 
the epide rmis, it is con ceiva b le ti13 t alte ratio ns in ex posed skin 
cells m ay be the so urce of certa in syste mi c imll1un o logic abnor-
m alities present in animal s ex posed to subca rcin ogeni c d oses of 
UVR . O ne such de fin ed iml11un o log ic a ltera tio n is m anifes t b y 
th e in abili ty of UVR-ex posed m ice to rej ec t hi g hl y immunogeni c 
UV R-reg resso r tum o rs, the m ajo rit y of w hi ch fail to g row w hen 
tra lls plan ted into no rm al sy ngeneic animal s 11 0, 11] . It is well 
es tablis hed that thi s UVH-indu ced tum o r-susceptible s ta te is m e-
di ated b y a po pulati o n of suppresso r T ly mph ocy tes (Ts cell s) 
tha t a rc specifi c fo r co mm o n tum o r- associated an t igens (TA A) 
C M C: ce ll - mediated cy totox icity 
COil A: concanava lin A 
D LN : dra ining IYl11 ph nodc(s) 
M CA: l11et hylcho bnthrenc 
M EM: modi fi cation of Eag le 's min imal ('sselltia l mediulll 
NI< : natu ra l killer 
l' US: phosph ate-bu ffe red sa line 
PEC: pe ritonea l ex udate ce ll s 
'fA A: tum or-associated antigcn(s) 
T ATA: tum o r-assoc i:\[ed trans plantation antigcl\ (s) 
T c ce ll : cyto tox ic T lymphocy te 
T s cell : supp resso r T lym phocyte 
U VR: ultrav io let rad iation 
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[ 13-15'1· Ex perilll ental ev idence sugges ts th at the ea rl y appea rance 
of these Ts cell s in U V R-ex: posed m icc provides an i IlImun o logic 
environlllent that allows for the emergence and progressive growth 
of these hi g hl y immunogenic regresso r type skill tum o rs 11 6, 17 1. 
However, the meall s by w hi ch the UVR-induced T s-cell popu-
lation arises prior to the development of overt skin tumors is not 
known, sin ce it is un certain how these Ts ce lls ga in specifi city 
for tum o r anti gells durin g the ea rly stages o f c lrcinogenes is. This 
criti ca l ques ti o n conce rnin g how T AA-specifi c T s cell s arc in-
duced has led to the h ypo thes is that subca rcinogeni c expos ure to 
UVR m ay be res ponsible for phenotyp ic changes in skin ce ll s 
that res ult in the exp ress ion of cross-reactive TAA li S, 191. 
Little is kn ow n about the stru ctural charac teristi cs of the cross-
reacti ve TAA ex pressed on the surfa ce of UVR-indu ced skin 
tumo r cell s. At presLllt , these cO lllm on TAA are bes t defi ned by 
their fun ctiona l chal'acte rist ics, e.g., th e ability of tumor cells to 
ind uce tum o r anti gen-specifi c cytotox ic T lymph ocytes (Tc ce lls) 
that arc ca pabl e of lys in g a var iety of tumors in v itro [20,2 1], and 
the cross-reactive protectio n agai nst different tumors that is ob-
served in mice that ha ve been repeated ly imilluni zed w ith the 
sa me sy ngeneic tUln o r [2 11. In a prev io us stud y, Robe rts et al 
[21] prov id ed ev idence that 2 fun cti onally distinct cross-reactive 
TAA arc associated w ith UVR tum o rs. In vivo , o ne of th ese 
TAA ap pea rs to function as a cross-reacti ve tumor-associated 
tra nsplantatio n antigen (TAT A) res po nsible for tumo r rejection 
ill tumor-immune anima ls, w hil e the other comm o n TAA ap-
pears to be recogni zed as an immullo regulato ry determinant by 
the UVR-induced Ts-cell po pulat io n. III contrast to w hat is ob-
served in vivo, Tc cells that d ifferen tiate , in vitro, from cultured 
dra inin g lymph node (DLN ) cell s obta ined fro m mi ce imlllunized 
w ith UVR tum o rs, al'C capa ble of fun ctionally recogni zin g both 
of the in vivo-defi lled, cross-reactive TAA. It remains unclear 
w h y Tc ce lls that differentiate in vitro, but no t in vivo, arc ab le 
to recognize both the cross-reactive TAT A and the co mm o n 
im mun o regul ato ry TAA o n tum o r target cells. Rega rdless of the 
mechanism, this p rov ides an immun o log ic assay that ca n be em-
p loyed to id entify and eva luate the immunogeni c pro perties of 
these va ri o us TAA. 
T he present stud y empl oys th e in vitro functional assay for 
TAA-specifi c Tc ce lls to demo nstrate antigens t1ut arc cross-
reactive with TAA on epid ermal cells obtained from mi ce that 
have been ex posed to subca rcinogeni c doses of UVR. B y im-
m uni zin g syngeneic mi ce w ith either UVR-ex posed epiderm al o r 
UVR tumor cell s, Tc cells with broad tumor specifi city were 
ind uced . In contrast, immunizat ion w ith no rm al skin cell s did 
not induce effecto r ce ll s capa ble of tum o r I ys is . These res ults 
provide furth er ev iden ce that UVR-ex posed epidermal cells arc 
induced to express cross-reacti ve TAA l iS, 191. Sin ce these an-
tigens eli cited an immune respo nse that was ana lyzed by eva lu-
at in g th e lyt ic activity of in v itro-deri ved T c cell s, it is likel y that 
they rep resent th e co mm o n immuno regula to ry TAA associated 
w ith vario us UVI~-i nduced and chemi ca ll y indu ced murin e sk in 
tul110 rs 12 11 . Thus, th ese data suppo rt the h ypothes is that the 
ea rly appea ran ce of co ml11 o n TAA in the skin of mi ce ex posed 
to UVR m ay be respo nsible for the indu cti on of TAA-specific 
Ts cells in UVR-exposed l11i ce before th e em ergence of overt sk in 
tumors . 
MATERIALS AND M ETH ODS 
Animals N o rmal , 8- to 12-week-o ld , female C3H / HeN (M am-
mary Tumor Virus - ) mi ce, o btained under the N ationa l Ca ncer 
Ins ti tute co ntra ct fro m th e Frede ri ck Ca nce r Resea rch Faci lity 
(Frede rick, M ary land), we re ho used at a density of5 animals pCI' 
standa rd 7 X 11-inch cage and m aintain ed on Way ne Steri lizable 
Lab B lox w ith acidifi ed wa ter ad libitum. 
U ltraviolet Irradiation The method of UV irradiation ha s 
prev io usly been described in detail 1111 . III this stud y, the UVR 
source consisted of 6 FS-40 West in ghouse Auorescent sunlamps, 
emitti ng > 60% of th e energy in the UVB range. Mi ce used in 
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these ex perim ents were exposed to approx im ately 5400 J / m 2/ day 
given in 30-min periods/da y,S da ys/week, for 6-10 weeks. 
Epiderm.al Cell Preparation and Foot-Pad Immunization 
Ea r, tai l, and sha ved back sk in was rem oved from bo th no rm al 
and UVR-treated mi ce after ether euth anas ia . T he skin was Aoated 
epidermis-side-up in 1 % trypsi n-phosphate-butTered sal ine (PBS), 
pH 7.2, at 37°C for 30 min . Epiderm al sheets were teased off th e 
derl11is and di ced with sca lpel blades to o btain a sin gle cell sus-
pension. The ce lls were then fi ltered throu gh a sm all am o unt of 
wetted n ylo n wool to remove deb ris, and washed twice by cen-
trifuga tion in PBS. Cell suspensions of the UVR-indu ced tumor 
LR-298 we re o btained from m onolayer cultures as described in 
th e next section and we re was hed tw ice in PBS. E pidermal and 
LR-29S cell preparations were determined to be > 95% viab le by 
try pan blue excl usion and were adjusted to a concentrat ion of 
2 x 107 ce lls / ml in PBS. N o rm al syngeneic mi ce we re iml11unized 
b y inj ecting I X 10" cell s in 50 }.L I PBS into th e subcuta neous 
ti ss ue of each foot pad. Each immuniza tion g roup consisted of 3 
anim als . 
Tumor Cells and Chromium-51 (s'Cr) Labeling Table I lists 
the target cell types used in the 6-h 5lCr-release assay. Tumors 
used for targets or immunization were g row n as m ono laye rs in 
gelatin-coa ted 75-cm 2 Aasks in a humidifi ed incubator at 37°C 
and a 5% CO 2 atm os phere. Alpha-mod ifi ca ti on of Eagle's min-
im al essential m ed ium (M E M , Flow Laboratories , M cLea n , Vir-
g inia) containin g 10% feta l ca lf se rum , 50 U / ml peni cillin , 50 
}.Lg/ 1lI1 st repto m ycin , and 2 mM g lutamine was changed week ly. 
Tumor cell s were rem oved from the Aasks by incubating the 
mono laye r for 1-2 min in Hanks' balanced salt so lu tion (S ig ma 
C hemica l Co., St. Lo ui s, Misso uri) plus 0.25% trypsin-EDT A, 
and washed tw ice in PBS. Peritoneal ex udate cells (PEC) were 
indu ced in C3 H mice by an i. p. inj ectio n of2 m1 3% thiog lyco ll ate 
4 days prio r to slC r labelin g. Conca navalin A (Con A, Sig m a 
C hcmi cals)-stimu lated Iymph o blasts were generated by in cubat-
in g no rm al 3H / HeN splenocytes at 4 X 106 ce lls/ ml in cOl11plete 
RPMI (RPMI 1640, H azleto n Products, Denver, Pen nsylva nia , 
suppl em ented w ith 10% feta l ca lfserum, 2 m M g lutamin e, 1 111M 
sod ium pyruvate, O. I mM nonessential amin o acids, 50 }.Lg / ml 
strepto m ycin , and 50 U / ml peni cillin) plus 2 }.Lg / ml Con A at 
3rC and a 5% CO 2 humidifi ed at l11 0sphere for 3 days . YA C-l 
ce ll s, a sensiti ve target for murine natural ki ller (NK) cells 122], 
were g rown in co mpl ete RPML For labelin g the target cells w ith 
51 1' , 100 }.LC i of sod ium chrom ate-5 1 (N ew E ng land Nu clea r, 
Boston, M assachusetts) in a 100 }.L1 volume was added to 1 X 106 
ce lls and in cubated in a 37°C wa ter bath for 60 min w ith gentle 
shakin g every 15 min . The cells were then was hed 3 times in 
excess M E M and resuspended in com plete I1PMI at l X 105 
cells/ m !. 
Cell-Mediated Cytotoxicity (CMC) Assay Complete detai ls 
of this aSS3Y arc desc ribed elsewhere [23 1. BrieAy, 8 days follow-
Table L Cells U sed for Targets in the Cell-Mediated 
Cytotoxicity (CMC) Assays 
Cdl Li ne" Murinc O rigin /> H-2 Haplotype' Inducin g Agcnr" 
L1~-2l)8 C3 H/ l-lcN 1-I _2k UV l~ 
LH-J35 3H/ HcN H_2k UVl~ 
L1~-8 C3 H/ HeN . H_2k Mcth ylchobllthrcnc 
I3CW-8 I3ALl3 /c Wchi 1-I_2d UV l~ 
BC W-1 9 BALB/c Wchi H_2d UVR 
PEC C31-1 / HcN H_2k Thiogl ycolbtc 
Lymphoblasts C31-1 / HcN H-2' Concanava lin A 
YA C-I A/Sn H-2" Moloney virus 
" L R-2~8 , Ln-33S. LH-8. BCW-8. anel BCW-19 Jrl' skin tumors. PEC are peri-
tOllca l ex udate celis. Lymphoblasts :In': der ivcd fro lll 110rm:11 sph~ lI ocy tcs. Y AC- I 
is a IYlllpho l1l 3 cdl lill t' . 
"M o use srr:tin frDl Il w hich rile ce lls were: derived. 
fH _2 haplo type of th e dcs ig n:ttL'd IlI Ollse strain . 
JAgclH used for inducing rhe v:l ri o lls cel l lines. UV )"\ :::: ul traviolet radiation. 
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in g foo t- pad immuniza tion w ith either epiderm al cells o r tum o r 
cel ls, the D LN (po pliteal, brachial, and axillary) were remo ved 
and dissociated in to sing le cell suspensio ns. Control lymph nodes 
(C LN ) were o btained from no rm al animals th at had been foo t-
pad immunized with PBS. Vario us C LN and DLN cell suspen-
sions consisted of poo led lymph node cell s obtained fro m the 3 
anim als in each immunization and control group . Cells were washed 
once and cultured at 37°C in a humidified 5% CO2 atm osphere 
in upri g ht 25-cm 2 fl asks at a concentrati on o f 3 x 107 cell s/20 ml 
complete RPMlIflask. After 4 days in culture, the cells were counted 
and resuspended at 5 X 10" viable cells/ml in co m plete RPM!. 
O ne hun dred mi croliters o f thi s cell suspensio n was then cocul-
tured at 37°C, 5% CO2 w ith 100 J.LI of th e s'C r-l abelcd target 
cells in V-bo tto m , 96-well , mi cro ti te r plates to give an effecto r-
to-target ratio of 50:1. Fo r cold-cell inhibition studies, s'C r-la-
belcd targets were suspended at 2 x 105 cells/ml co mplete RPMI , 
and 50 J.LI were added to each well to maintain the sam e effector-
to-l abeled targe t cell rati o o f 50: 1. T o these wells 50 t.d o f unla-
beled cold ta rget cells at 8 X 105 cells/ml we re added simulta-
neously to give an unl abeled-to-Iabeled target cell ratio of 4:l. 
All sa m ples were do ne in tripli ca te and after a 6-h incubation, 
100 J.LI of supern atant was removed and counted in a Packard 
Multi-Pri as gamma co unter (Santa Ana , Ca lifo rnia) . The per-
centage of specifi c 5lC r-release was calcul ated as: 
(ex perim ental - cont rol) X 100 
to tal release - spontaneous release' 
where colllrol represen ts cpm rel eased by targets in cubated w ith 
C LN cells and experilllclltal represents cpm released by targets 
incubated w ith DLN cells. T o tal [elease was es tab lished by lys is 
o f 100 J.LI of labeled tUlll o r cell suspension with '1 % N o nid et P-
40 detergent, and spontaneous release equ aled cpm in the super-
natant o f labeled tum o r cells incubated with medium alo ne. Data 
are presented as the mean % specific lysis ± SEM of the triplicate 
well s run fo r each cell target and cytotox ic cell populati on. 
Statistical Analysis .Statistica lly sig nifi ca nt differences in the 
% specifi c lys is o f cell targets by va rio us cytotox ic cell po pulati ons 
we re de termin ed by the Student's I- tes t. P-va lues were ca lculated 
fro m comparisons between the mean slCr release (cpm) of trip-
li ca te well s run fo r each cell target and cytotoxic cell populatio n. 
RES ULTS 
Cytotoxic Cells Induced by UVR-Exposed Skin Immuni-
zation Foo t-pad iml1luniza ti on w ith UVR-exposed epidermal 
cell s induces a po pulation o f cells w ithin th e DLN th at differ-
entiate into cytotoxic cell s ca pable o f lys ing a va riety o f skin 
tum o rs. T he results of3 experim ents presented in T able II com-
pare tum o r cell lys is mediated by cultured DLN cells obtained 
fro m mice that were foot-pad immunized w ith either no rm al skin 
o r UVR-ex posed skin cells. Discrepancies in lytic ac ti vity amo ng 
experim ents arc cO lllmon and are mos t likel y du e to a number 
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of va riables w ithin the assay syste m . T hese include differenti al 
growth rates of target cells at the time of harves tin g, va riabil ity 
in the effecti veness o f iminuni za tio n in different g roups of mice, 
and d ifferences in the degree o f m3turatio n o f D LN cell s durin~ 
th e 4-day culture period . Each experim ent, however, demon~ 
strated a clear trend in the capabilities o f the different D LN cells 
to mature into cyto toxic cells and lyse UVP.-induced tum o r tar_ 
gets. Specifi cally, im.1l1unization with no rm al skin cells consist_ 
entl y fa iled to produ ce cy to tox ic cell s ca pable o f an y signifi cant 
tum or lys is of the 2 syngeneic UVR-tumo r targets tes ted, LR-
298 and LR-335. In contrast, all 3 ex perim en ts demonstrated th at 
D LN cells removed from mice immunized with UVR-cx posed 
skin cell s matu red into cy to tox ic cells that we re ca pable o f lys ing 
UVR-tumo r targets to a mu ch grea ter ex tent. 
Spectrum of Target Cell Recognition by Cytotoxic C ells 
To determin e th e spectrum of target cells th at are recognized b y 
cy totoxic cells induced by immuniza ti on w ith UVH-ex posed skin 
cells, a battery of differen t target cell types was tes ted , as sho'''''11 
in T able III. In these experim ents, th e lyti c ac ti vity of cytotoxic 
cell s o btained fro m anim als immunized with epiderm al cells is 
compared to that o f cy totoxic cells deri ved fro m mi ce immunized 
w ith LR-298 UVR-tumo r cells. In experim ent 1, DLN cells har-
ves ted fro m mice immunized w ith no rm al skin cell s showed mi n-
imal lys is fo r the 5 targets tes ted . In comparison , immunization 
with UVR-ex posed skin cell s o r LR-298 tum o r cells consistentl y 
yielded cytotoxic cells that were capablc of lys ing the syngeneic, 
UVR-induced tum o rs LR-298 and LR-335. In addition , both cy-
totoxic cell populations lysed the C3H meth ylcholanthrene (MCA)-
induced tumor LR-8. Alth ough these cyto tox ic cells lysed a range 
of skin tum or targe ts, they appeared to be specifi c fo r T AA , since 
they displa yed minimal po tential fo r the killin g o f syngeneic PEe 
and Con A lymph oblas ts. In ex perim ent 2, it was sho wn that 
UVR-induced tum o rs o f B ALB/c o ri gin (designated BC W-8 and 
BCW-1 9) were also effectively lysed by cytotox ic ceJls induced 
by LH-298 or UVR-ex posed skin cell immunization. In this ex-
perim ent, DLN cells o btained fro m mi ce immunized w ith norm al 
skin cells we re no t tes ted fo r th eir lytic activity against allogeneic 
cell targets, since we have never observed any appreciable level 
of cytotoxic cell activity in this cell po pulation compared to that 
observed when UVR-ex posed skin cells are used for immuni-
za tion. In a separate experim ent this lack of cytotoxic cell activity 
in the D LN of normal cell immune mi ce was confirm ed , e.g., 
% specific lysis of BC W-8, BCW-1 9, and LR-335 by these cells 
was 2.0 :!: 1. 0, 0.6 ± 0.9, and 7. 1 ± 1. 0, res pecti vely. These 
results indi ca te th at MH C-res tricted killin g o f UVR-induced tu-
mo rs is no t a fea ture o f these cyto tox ic cells, a findin g that is 
consistent w ith ea rli er repo rts 120,21]. 
T o analyze th e level of NK-cell ac ti vity in these D LN popu-
lati ons, Y AC-l target cells we re also tes ted (Ta ble III, ex perimen t 
2). T he Y AC-l target cells wen: not lysed by DLN cells obtained 
fro m mi ce immunized with LR-298 o r UVR-exposed skin cells. 
Table II. Compariso n of Tumo r Lysis by C ultured Draining Lymph N ode Cell s from Syngeneic Mice Immunized w ith E ither 
N o rm al o r Ul trav io let Radiation (UVH)-Ex posed Skin Cells 
ill1111uni za tion 
of DLN DOl1 or" 




5.8 :!: 0 .6' 
15.9 :!: 0.9 
Percent Specific Release" 
Experiment 2 
LR-2lJ8 
3.9 :!: 0.8 
20.4 :!: 2.3 
Ex pe ri 111 ent 3 
LH-298 LH-335 
1.3 :!: 1.1 
71.2 ± 3 .6 
13.5 ± 1.3 
72.7 ± 1.3 
"Lyti c acti vi ty ill 4-day cultures of drai nin g lymph node cel ls ob r:ti ncd (ro m no rm al synge neic C3H mouse fOOl- pad immunized 8 da ys prev io usly w ith normal or UVR-
ex posed epidermal cells. D LN = draining lymph node(s). 
"Resul ts of 6- 11 s'Cr_rclease assay are presented as the mea n of trip lica te samples ± SE M . U VR- tlIlll ors LJ1-298 o r LR-335 used as ta rgets. T he b bclin g indices for rhe 
va rious tu lll or targets were as follows: LR-298 sponta neous ~ 3,969 cpm , total = 20,986 cp m (Expe riment I); spontaneous = 1. 725 cp m, to tal = 12,575 cpm (Experiment 
2); sponta ncous = 1,064 cpm, tota l = 5,993 cp m (Ex perim ent 3); and LR-335 spo ntaneo us = 963 Cp lll , total = 6.880 Cplll . 
(D irrere nces in the o/c) specific lys is of tU lll o r targets by no rm al skin and U V I1-skin- induced cytotox ic ce lls were statistica ll y s ig nifi ca nt at (he ro llowillg: p s 0.02 
(Experiment I); Jl :S 0.00 1 (Ex periment 2); and Jl :S 0.00 1 for both tllmor targets in Experiment 3. 
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Table III. Spectrum of Lytic Acti vity Displayed by 
Cytotox ic Ce lls O btained From Mice Immunized With 
Norma l Sk in , UVR-Exposed Skin , o r LR-298 Tumor Cells 
Immunization 


























Percent Specific Release' 
Experi lllcnt I Experi ment 2 
7. 1 ± 2. 1" - ,. 
6.S ± 1.6 
2.9 ± 1. 2 
3.4 ± 0.4 
6.6 ± 1.3 
39.6 ± 6.S 51 .2 ± 4. 1 
21.1 ± 1.3 24.9 ± 1.6 
29.7 ± 3.2 73.S ± 3. 1 
33.5 ± 1. 9 
55.7 ± 1.3 
3.9 ± 0.6 2.2 ± 0.3 
2.3 ± 1. 9 
0.0 ± 1.9 
55.3 ± 20.0 56.3 ± 2.7 
22.9 ± 0.9 30.3 ± 0.9 
45.2 ± 7. 1 74.1 ± 3.9 
60.6 ± 4.S 
59. 1 ± 2.0 
9.7 ± 0.7 4.9 ± 0.3 
13.3 ± 0.9 
5.S :!: 2.6 
' Lytic activi t y in 4-day cultures or draining lym ph node (DLN) cell s obtai ned 
from normal syngenei c C3H mi ce immun ized 8 days previously w ith no rma l skin. 
UV R-skin , or LR-298 UVR-tumo r cells. 
' See Ta ble I ro r descriptio ns or target cells. The bbelin g ind ices ro r the vario us 
cell ta rgets were as ro ll ows: LR-298 spo lltaneolls = 723 cpm. tot:!1 = 5. 111 cp m 
(Experiment I), spontaneous = 1.206 Cp l1l . toto l = 15,8 17 cpm (Experi ment 2); 
LR-335 sponta neous = I ,40il cp m . tota l = 7. 190 cp m (Ex perim ent I). spontoneous 
= 2, 168 cpm . to ta l = 13,585 Cplll (Ex periment 2): Ln-8 spontaneo us = 855 cpm. 
tota l = 5,825 cp m (Ex perim ent I). spontaneo us = 1,35 1 cp m . tota l = 10,980 cpm 
(Experiment 2): lJ CW-8 spontaneous = 1.992 cp m , total = 11 ,952 cpm: I3 CW- 19 
sponta neous = 1. 784 cpm, ,ota l = 7.0 13 cp m : perito ncal ex udate cells (PEC) 
spontan eous = 830 cpm. to ,,,1 = 4.08'.1 cpm (Experiment I), spontaneous = 2,562 
cpm. toto l = 10. 19 1 cp m (Experim ellt 2); Iymphobbsts spontaneous = 60 1 cp m . 
tota l = 1.286 cpm: and VAC- I spon ta neo us = 1.465 cpm , to tal = 6.824 Cplll . 
"Resu lts o f u-h 5lC r-rclcasc aSS:lY :Ire pn:scntcd as the mean of trip licate sa mples 
:!: SEM. 
JD iffc rcnces in the % specific lysis of tllJllor t:1 rgcts by non ll:11 skin in duced 
cytotoxic cells co mpared wit h UVR-skin and LR-298 induced cytotoxic cel ls were 
statistica ll y sig n ifi cant at the ro llowing: I' S 0.00 1 ror LR-298, and I' S 0.005 ror 
LR-335 and Ln.-8. DifTerenccs in the U/u specifi c lys is of tUTll o r t:1rgc[s co mpared to 
PEC, YAC-I. and Iym phoblasts by UVn-sk in and Ln-298 ind uced cytotox ic ce ll s 
were sta tistica ll y sig nifl ca llt at I' S 0.001. 
(Dash indic:1 tcs th at target was not tested. 
Tn this study lys is of Y AC-1 cells by the C LN po pulation was 
app roximately 4% specifi c lys is (data not shown). Th is suggests 
that NK-cell ac ti vi ty in the DLN cell populati ons induced by LR-
298 or UVR-ex posed sk in cell imm uniza tio n was no t significa ntl y 
enhanced and does not playa maj o r ro le in th e lys is of the tumor 
targets tested. 
Cross-Reactivity of Antigens Recognized by Cytotoxic Cells 
Tn the experim ents already described , it is apparent that cytotoxic 
cell s elicited by UVR-ex posed sk in and UVR-induced tumor cell 
im muni zation recognize cell-surface antigens common to a broad 
spectrum of skin tum ors. To substa nti ate this conclusion , co ld 
ceJl inhibition studi es were ca rried out to determ ine w hether th e 
antigens recog nized by these d ifferent cytotoxic cell po pulations 
represented cross-reactive TA A. Fo r thest:: experim ents, labeled 
and unlabeled target cells we re added to the C M C assay at a rat io 
of 1:4, respecti vely. T he effecto r cell-to-Iabeled-target cel l ratio 
in these assays was mai ntained at 50:1 . In Table IV, cytotoxic 
cell s o btained from anim als immunized with UVR-exposed skin 
cells or LR-298 tum o r cells are compared for their lyti c activity 
aga inst the 5lC r-labeled tumors LR-298, LR-335, and LR-8. T he 
in hibition of lys is of these 3 differen t tum o rs foll owin g the ad-
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Table IV. Cold Cell Inhibition of TUll10r Lysis by Cytotoxic 
Cell s O btained From Mice Immunized With UVR-Exposed 
Skin Cells o r LR-298 T um or Cell s 
Percent 
Imlllunization Labeled Cold Specific Percent 
of DLN Donor" Targct/' Inhibitor' Release" Inhi bition" 
UVR-sk in LR-29S N one 51.3 ± 4.1 
PEC 53.1 ± 3.9 0 
LR-335 IS.9 ± 3.5 63 
LR-S 10.4 ± 3.5 SO 
BCW-8 27.2 ± 4. 1 47 
LR-335 None 24.9 ± 1.6 
PEC 23.5 ± 1.4 6 
LR-298 12.0 ± 0.6 52 
LR-S 13.9 ± 1.3 44 
BCW-S 12. 1 ± 1. 0 49 
LH-S None 73.8 ± 3. 1 
PEC 60.S ± 5.3 18 
LR-335 21. 2 ± 1.3 7 1 
LR-29S 23.6 ± 6. 1 6S 
BCW-8 32.2 ± 2.S 56 
LR-29S LR-298 N one 56.3 ± 2.7 
PEC 53.9 ± 3.4 4 
LR-335 24.7 ± 5.0 56 
LR-S 24.5 ± 5.S 56 
I3CW-8 2S. 1 ± 4.0 50 
LR-335 None 30.3 ± 0.9 
PEC 2S.9 ± 0.6 5 
LR-298 11. 5 ± 2.0 62 
LR-8 7.9 ± 1.1 74 
BCW-S 6.9 ± 1. 5 77 
LR-S None 74. 1 ± 3.9 
PEC 69.6 ± 2.S 6 
LR-335 20.S ± 2.9 72 
LR-298 29.6 ± 3. 1 60 
BCW-S 34. 1 ± 4.4 54 
' Lyti c activ ity in 4-da y cultures or draini ng lymph node (DLN) cells obta ined 
fro l11 110 rm:11 syngeneic C3H m icc immunized 8 days prev io usly w ith uvn-cxposed 
skin or LR-298 UVR-,umo r cells. 
"Sec Table I ror desc rip tions or target cells. Ih ri o or C),totoxic cell s to S1Cr-labeled 
targct cells was 50: I . T he labelin g indi ces for the v:1rioll s [lIlll o r t:1rgets were as 
rollows: LR-298 spo n, aneous = 1,206 cp m , to tal = 15,8 17: LR-335 spontaneous 
= 2. 168 cpm. to tal = 13.585 cpm: and LR-8 spontaneous = 1,350 cp m . tota l = 
10.980 cp m. 
' Rat io or unla beled target cell s to S1C r- bbcled target cells was 4 : I . 
Jltcsults of 6-h slCr-rcieasc assay arc presentcd as th e 111 ean of triplica te sa mp les 
± SEM. Diffc rcnces in the % specific lys is o f the UVR-tu lllo r larget cells inhibited 
by the addition or co ld tumor cell s co m pared to the add ition or cold peritoneal 
exudate cells (p EC) ror all tumo r ta rgets by either UVn-ski n o r L1~-298 indu ced 
cytotox ic cd ls were staristi c:1 l1 y sig nifi C:lI1 t at p :5 0.005. For all tumor ta rgets and 
cytotox ic cells ,es ted the addition or co ld PEC did no t signi ficantl y dimi nish the % 
specific lys is (1' 2: 0.05). 
"T'his refers to the % inhibitio n in specifi c release achi eved wi th th e addit io n of 
cold inhibitor cells in comparison to the specific release achi eved witho ut add ition 
or co ld inh ibitor cells. 
diti on of unl abeled target cells was measured and compared to 
the amount of tumor lys is obtained in wells cultured witho ut 
unlabeled cells. In aU cases, the addition of unlabeled PEC resulted 
in minimal inhibi tion of labeled target cell lys is, demonstrating 
that the dilutional effect in thi s assay was of min o r impo rtance, 
and also that PEC do not express T A A. In contr:lst to this is cold 
cell inhi bit ion with UVR-tumor cells: of sy ngeneic or allogeneic 
o ri gin (LR-298, LR-335, BCW-8), and syngeneic MCA-i '1d uced 
ori gin (L R-8), all resulted in a signifi ca nt decrease o fl abeled target 
cell killin g. T hese data indi ca te th at cy totoxic cells induced by 
UVR-exposed skin and U VR-indLi ced tumor cell immunization 
recognized TAA, w hi ch are expressed by all the sk in tumors that 
were tested. Although th e biochem ica l nature of these croSS-re-
ac ti ve T AA is unknown, the resu lts of these analyses suggest that 
th e cytotox ic cell s described here recognize, at least in part, the 
common immuno regul atory TAA that was previously demon-
strated by this type of ex perimental assay [21 1. 
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Localized Expression of Antigens Cross-Reactive With TAA 
Alth o ugh the results presented thus fa r indica ted th at anti gens 
th at a rc cross-reacti ve w ith TAA arc present in the epidermi s o f 
UVn.-ex posed mi ce, it was un certa in w hether UVR ca used a loca l 
ex press ion of these antigens onl y in skin sites th at arc d irectl y 
ex posed to th e radiat io n source, o r w hether a systemi c change in 
th e epidermis o f UVR-exposed animal s occurs. To address thi s 
qu esti on , animal s were immunized w ith e ither abd o minal skin 
cell s (a n area pro tected from direct ex pos ure to the UVR source) 
o r back skin ce lls (directl y exposed to the UVR source) fro m th e 
sa me UVR-trea ted anim al. In T able V, lys is o f target LR-298 is 
shown to be minimal by cells o btained fro m th e DLN o f J11i ce 
immunized w ith sk in ce lls no t directl y ex posed to UVn. (e.g., 
abdo min al sk in fro m UVR-exposed mi ce and back skin fro m 
no rm al no n-UVR-exposed anim als). In co mparison , cyto tox ic 
cells obtain ed fro m mi ce imJ11unized w ith skin cells that we re 
ex posed d irectly to the radiati o n source (UVR-ex posed back skin) 
resul ted in m arked lys is of LH.-298 cells . It is conclud ed fro m 
th ese results that the in d uced ex press io n of anti gens that are cross-
reactive w ith T AA in the skin o f UVn.-treated mice appears to 
be a loca li zed pheno menon associated w ith skin ce ll s ex posed 
directl y to th e UVR so urce . 
DI SC U SSIO N 
This stud y demo nstrates th e presence of anti gens in UVH.-ex-
posed skin th at arc cross-reacti ve w ith the T AA expressed on the 
cell surfaces of skin tum o rs of di verse o rigi ns. Utili zin g a com-
binatio n of in vivo immunizatio n w ith UVR-exposed skin o r 
UVl1- indu ced tum o r cells fo llowed by in vitro cul ture o f DLN 
ce ll s, cy to tox ic cells that recognize cross-reactive T AA were 
produ ced. A marked difference in th e lyti c ca pability of effector 
cells that m atured fro m DLN cd l po pulati ons o btained fro m mi ce 
afte r immuniza ti o n with normal epidermal cell s as compared to 
UVR-exposed epidermal cells was o bserved . Cyto toxic cell s ca-
pable of lys ing tum o r cell lin es were generated w hen UVR-ex-
posed skin cells and UVR-induced tum o r ce ll s were used fo r 
imllluni zat io n. In contras t, preparati ons o f epiderm al cell s o b-
ta ined fro m no rlll aimice o r pro tected skin sites of UVn.-ex posed 
anim als contain either no antigens that are cross-reacti ve w ith 
T AA or qu anti ties o f th ese antigens that arc insuffi cient to induce 
tUlll o r-specific cyto tox ic cell s. 
T hree lines o f ex perim ental ev idence suggest th at the cy to tox ic 
cell s c.Ii cited by imllluniza tio n w ith UV- irradi ated (UVR)-skin 
ce lls are fun cti onall y simil ar to th ose induced by UVR- tum o r 
cell s. First, th e w ide spectrum o f tum o r cell types lysed by cy-
to tox ic cells indu ced after UVR-skin immuniza ti on is qualita-
ti vely id enti cal to the broad specifi city o f TAA-specific T c cell s 
deri ved fro m C3H mi ce immunized w ith sy ngeneic UVR-in-
d uced tum o r cell s [20,211. U sin g cold cell inhibition assays , it 
has prev io usly been demonstrated th at antitumo r acti vities w ithin 
these tum or-induced Tc-ceLl populations arc directed aga inst T AA 
present o n bo th UVR- and M C A-indu ced tum o rs, as well as 
Table V. Compari son of Abd o min al Skin and Back Skin 
Fro m UVR-Exposed Mice fo r Their Ex pressio n o f 
C ross-Reactive TAA 
Immunization o f DLN Donor" 
Back skin fro lll UVR-cxposcd mice 
Abdo mi na l sk in fro m U Vn-exposed mice 
Back sk ill from norm al mice 
T arget LR-298 Percent 
Specifi c Release" 
7 1. 2 ± 3.6 
0.8 ± 0.9 
1.3 ± 1. I 
"Ly ric ac tivity in 4-d:ty cultu res of d ra inin g ly m p h Il o d t,' (O LN) cell s obtain cd 
fro lll Il o rmal syngeneic C3H m ice immun ized 8 cl:l ys previo usly w ith back o r 
abdo lllin al sk in cells. 
1!1l.csul ts o f 6-h sICr-rclc:lsc aSS:1Y a rc presented :lS the mean of tripli ca te $:1I11 p IC5 
± SEM. T il l." I::J bcli Jl g index fo r LH.-298 was spOllta n eO liS :::: lU64 Cp l1l :Illd tor:t l = 
5993 Cplll . D iffere nces in th e % specific lys is of LR-29R target cell s by U YH-sk in 
in d uced cOlli pa red [ 0 no rm al back ;1I1d Il o n-U VH.-cx posc..:d abdo minal skin indu ced 
c YLO ro:( i c c(.' lI s w(' n .' st :ltis ti c;:lIl y s ig nifi cant :1t p S 0.00 1. 
T H E JO UHNA L OF INVESTIGATIVE DE ltMATO LOGY 
ce rtain skin tum o rs of diffe rent 1-1-2 haploty pes r20,21]. A sim ilar 
res ult was fo un d in thi s stud y fo r bo th tumo r-indu ced and UV R_ 
skin indu ced cyto toxic ce lls. Bo th types o fill1ll1uni za ti on resul ted 
in cytotOx ic cell s capa ble of lys in g, in add iti o n to numerous syn_ 
geneic UVR- tulll o rs, a M C A-tulll o r LR-8, and allogeneic BALB /e 
UVl1- tum o rs B C W-S and B C W-1 9. 
Second , des pite reactivity w ith skin tum o rs o f di verse o ri g in , 
these cy to tox ic cells showed min im al ly ti c acti vity aga inst syn-
geneic PEC o r Con A Iympho blasts . Thi s differs fro m so m e of 
the no n-T A A-specifi c I ym pho kin e-ac tivated kille r cells described 
by Rosenstein et a11 24 1. These broadl y reacti ve muritH: cyto tox ic 
cell s do not lyse nor mal ly mphocy tes but ha ve been shown to 
kill Iymph o blas ts . In these studi es, UVR-skin and UVl1-tumor 
indu ced cyto tox ic cell s were also shown to be in capable o f lys ing 
YA C-1 target ce lls, w hi ch are highl y sensiti ve targets fo r mu rine 
NK cell s 122"1. In these ex perimen ts o nl y a sm all degree o f N K 
ac ti vity w as o bserved in th e DLN cell po pulatio ns o f mi ce im -
Illunized w ith either UVR-induced tum o r o r UVR-ex poscd skill 
ce lls. 
Finall y, th e pheno ty pe o f the cyto to xic cell s induced by UV R -
skin and UVH.-tum o r ce ll immuniza tio n wa s fo und to be id en-
ti ca l, as determined b y trea tin g cytotox ic cell s w ith antibody and 
rabbit co mplement just prio r to the C M C assay (H o ng and Ro b-
errs, m anu script submi tted fo r publi ca tio n). The pheno type of 
th e cyto tox ic cell s was fo und to be th e fo ll owin g: Th y 1. 2 + , Lyt 
1.1 + , Lyt 2 .1 r , L3T 4 - , and as ialo G M 1 - . Sin ce immunization 
wi th UVR-skin and UVR-tumor cell s induces T h y 1 ~, Lyt 1 +2 + 
Tc cell s w ith specifi city fo r TAA , it is unlike ly that an inAam-
mato ry respo nse seco nd ary to the immunizatio n process is re-
spo nsible fo r th e lyti c acti vity seen in th ese ex perim ents. In ad-
diti on , immuniza ti on w ith Freund 's co mplete adjuvant docs nor 
produ ce antitumo r ce ll s des pite an extcnsive inflammatory in fi l-
trate in the DLN (d ata no t show n) . Co ll ectiv ely, th ese data sug-
ges t tha t th e cross-reacti ve TAA shared by UVR- skin and UVR-
tum o r cells elicit a simil ar immune response w hen anal yzed by 
th e co mbin ed in vi vo immuniza tio n and in vitro cyto to xicity 
assay employed in this stud y. 
Fro m this stud y, it is unclea r w hi ch cpidermal cell type under-
goes anti geni c changes after exposure to subca rcinogeni c UV R 
that m akes it cross-reacti ve w ith TAA . Alth o ug h it is m ost likely 
that ke ratin ocy tes arc induced to ex press th ese anti gens, ex peri-
ments w ill need to be perfo rm ed w ith purifi ed epiderm al cell 
po pulatio ns to ad dress this qu cs ti o n. It is possible th at nonker-
atin ocyte epiderm al o r even dermal cells undergo UVH.-indu ced 
anti geni c changes. This is less likely considerin g the cell o rig in 
o f th e m aj o rity o f UVH.-indu ced tum o rs in haired mi ce. Ini tial 
descripti o ns o f the inductio n o fUVH-indu ced tum o rs in different 
mo use strains, o n th e basis o f mi crosco pi c cxa min ation o f tumor 
bio psy frag ments, indi ca ted a predo min ance o f spindle cell fi-
brosarco mas o ver squ amo us cell ca rcin o mas in UVR-treated mi ce 
r25,261. H owever, a mo re complete histo logic stud y, including 
keratin-specifi c stainin g, has recentl y dcm o nstrated that the m a-
j o rity o fUVR-indu ccd tum o rs arc ac tu all y o fk eratin ocy te o ri gin 
r27 1. It is also unknown wh ether the anti gens dem o nstrated in 
UVR-ex posed ep idermis arc also present in de rm al ti ss ue. It has 
been our ex pe ri ence, ho w ever, that ex perim entall y induced skin 
tum o rs arc lysed by TAA-specifi c T c cells rega rdless o f w hethe r 
th ey arc histo logica ll y described as being o f epiderma l (carcino m a) 
o r derm al (fibrosa rco ma) o ri g in 121 J. Ind ependent o f th e histo-
logic o ri g in o f th e tum o r, it is poss ibk that epiderm al cxpression 
o f TAA and the resultin g immunologic ch anges that occur in 
UVR-ex posed anim als m ay inAuence the g ro w th o f bo th epithe-
lial-de ri ved ca rcino m as and fibroblast- derived spindle cell fibro-
sa rco m as w ithin th e dermis throug h a similar immuno regul atory 
process . Ev idence to suppo rt this type of process is provided by 
the stud y of Mullen et al [28 1, who sho w ed th at the g rowth of 
o ne UVn.-indu ced tum o r could fa cilit"atc the develo pment, at 
ano th er site, o f a second cancer fro m prem ali gnant cells. 
The prescnce o f cross-reactive TAA in the skin o f animals 
ex posed to subca rcinogeni c doses o f UVR, prior to th e deve)-
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op ment of an y detectable neo pla sm, clearl y represents o ne cle-
ment required fo r th e indu cti o n of the UVR-induced Ts-cell po p-
ulatio n. The results of experimCllts employing a clo ned T s- cell 
li ne derived fro m mi ce exposed to s ubca rcin ogen ic UVR tends 
to suppo rt thi s conclu sion 1'1 5 1. I t was determined that th e fun c-
tional antigeni c specifi city o f these T s cell s, and poss ibl y the entire 
UV R-indu ced Ts-ce ll po pulati on , is limited to the recogniti o n of 
a cO lllm o n TAA ex pressed b y virtua ll y all UVI~-indu ced tum o rs. 
Altho ug h the ex act il11l11un o logic m ecluni sm by w hi ch these 
co 111 III o n TAA l11a y eli cit th e o bserved il11l11un o regul3to ry 1"1:-
sponse is unknown, at least two poss ibiliti es ma y be co nsid ered . 
First, sin ce cross-reJCti ve TAA arc presen t in epiderl11al ti ss ue 
exposed to UVR , th e presentati o n of these ant igens to the host 
th ro ug h an immuno logica ll y co mpro mi sed skin site ma y indu ce 
a TAA-specific Ts-cc ll res po nsc . T his m ay be du e to the dimin-
ished antigen presentati o n ca pacity b y a redu ctio n in the number 
or fun ctio n of Lan ge rhan s cell s in UVR-ex posed skin 13,29 1. o r 
an increase in pros ta g landin levels w hi ch inhibit no rm al immune 
res ponsiveness in UVR-ex posed mi ce 130 1. 
Second , resu lts o f recent ex periments pe rfo rmed in o ur labo-
rato ry have shown that foo t-pad immuniza ti o n w ith so luble pro-
te in extract from U V I~-exposcd skin cell s docs no t indu ce anti-
tU lll o r cyto tox ic cell s in th e DLN . If the sa m e prote in extract was 
incorpo rated into liposo lll es, howeve r, th eir immunogeni city was 
sim il ar to tlut o f w ho le UVR-exposed e pid ermal ce ll s . IlHe res t-
ingly, a tum o r-susceptible s tate was conferred to no rm al l11i ce by 
i. v. inj ec ti o ns of so luble pro tein ex tracts o btained fro m UVR-
exposed epiderma l cell prepara tio ns. Thus, the entry o f so luble 
TA A fro m UVR-ex posed skin into th e blood s tream m ay pre f-
erentiall y indu ce a s tate ofTs ce ll-m ediated UVR-tul11 o r to leran ce 
(Hong and Roberts, m anuscrip t submitted for publi ca ti o n). 
Aside fro l11 a few studies , ve ry little is kn ow n abo ut the bi o-
chel11i ca ln ature of the common TAA th at arc expressed by UVR-
wmo rs. I t has been repo rted that UVR-tumo rs ex press a cross-
reactive TAA that appears to be a 200 kD g lycopro tein 13 11. 
Em ploy ing m o noclonal antibod ies raised aga inst UVR-tumo rs, 
DeWitt and cowo rk ers 132 1 have ev id ence sugges tin g that th e 
cross-reactive TAA bo und by these antibodies is a g lyco lipid 
moiety associated with a 200-300 kD molecule. Severa l o f these 
T AA-specifi c m o no cl o nal antibodies were show n to bind to an-
t igcns extracted fro lll th e skin o f UVR-exposed anim als 133 1. 
Fo rtner et a11 34] have reported that UVR-tul11 o rs ex press v irall y 
cncoded gp70 anti gen o n th eir ce ll surfa ce . Similarl y, a stud y b y 
DeLu ca et al 135] sugges ts th at th e cross-reacti ve antibodi es in 
the serul11 of UVR-tumo r-iml11un e mi ce have specifi cit y for mu-
rine Icukcmia viral produ cts . Finall y, Beeson et al1 36 1, cmpl oyin g 
the sa l11e assay sys te m used in o ur stud y, have demonstrated the 
p resence o f o nco fetal an t igens o n UVR- and M C A-indu ced tu-
mo rs that arc ex pressed o n pla ccntal and fetal ti ssues . It is con-
ceiva ble that an y o f th e anti gens described abovc as cross-reactive 
TAA could fun ction as either cOlllm o n immuno reg uiJtory de-
terminants o r TATA w hen ex pressed by UVR-tum o rs. Alth o ug h 
these anti gens are defined as bein g TAA , the re is no reaso n to 
believe that th ey necessari ly repl'esellt novel 1Il 0 iecu ies associated 
w ith o r resultin g fro m th e tran sform ati o n process. It is m o re 
likely that Ill OS t o f the functiona ll y de fin ed cO l11m o n TAA arc 
norm al ce llular constituents that are poss ibl y inappro priately ex-
pressed due to the altered g row th and differentiati o n character-
is tics o f neo pla sti c ce ll s. This wo uld cx pl ain w hy these co mlTl o n 
TA A a ppea r to be associated w ith such a wide ran ge o f skin 
rumors 120,2 11. Furtherl11 o re, it wou ld fo ll ow that these same 
cross-reactive TAA mi g ht be ex pressed by UVn.-d am aged skin 
cell s. 
Des pite o ur la ck of kn owledge concernin g the nature of these 
com m o n TAA , th eir fun ction al importance for th e em ergence 
and progressio n o f m os t UVR-tum o rs is apparent. T hro ug h th eir 
exp ress io n o f a cO l11m o n immuno regubto ry determinant that is 
func tio nall y recogni zed b y the UVR-indu ced Ts-cell po pul atio n 
a majority of UVR-tulll o rs, w hich wo uld have been rejected had 
the ir host possessed no rmal imllluno logic cO lllpetency, arc ab le 
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to esca pe the il11lllune surveillance mcchanislTl s of their host 11 6,17 1. 
That 3n immuno reg ul ato ry circuit would evolve that pred isposes 
th e indi v idu al to the ea rl y de velo pment of skin tum ors seem s 
in co nsistent w ith the ro le of a protective imlllune sys te m . To 
expbin this di choto m y, Dayncs et al [371 have sugges ted a pos-
sible te leo logic ro le for the TAA-specifi c UVn.-indu ced Ts-cell 
popubti o n. They propose th at UVR-indu ced T s- celi s arc eli cited 
as a protective mechanism again st th e po tenti al devclo pment of 
auto immllne type di sea ses durin g the repair of UVn.-d amaged 
skin cell s. ' A similar immunoregulatory process, alth o ug h not 
necessa ril y TAA-specifi c, appea rs to be o peratio nal in anima ls 
fo ll owin g therma l dam age to their skin [381. T he evidence th at 
UV r~-exposed skin ce ll s ex press cross-reactive T AA suggests th at 
these anti gens arc res po nsible fo r e li citin g th e TAA-specifi c Ts-
cell res po nse that is obse rved in UVR-treated mi ce . Because th e 
UVR-indu ced Ts-cell population fun ctio ns b y an associative rec-
ognitio n mechanism (i.e., thro ug h its ability to recognize a weak ly 
immunogcni c co lllm o n TAA expressed by a wide ran ge of skin 
tum o rs. it is capab le o f b lockin g th e genera ti o n of tum o r rejec ti o n 
res po nses eli cited by st ro nge r tum o r-specific transpbntatio n an-
ti gCll s and cross-reacti ve TAT A), it pro vides fo r a large number 
o f tum o rs th e m os t effecti ve means for circumventin g immu-
no logic rej ect io n by their host [16,39]. 
Th us, th e express io n o f these sam e anti gens by develo pin g 
neoplasia allows th em to usc this preexistin g imllluno regulatory 
m echan ism provided by the UVn.-indu ced Ts-cell po pulati o n to 
escape immunc surveill ance. In this rega rd , the express io n of an y 
co mm o n ce ll surface co mpo nent o r an tigen, rega rdless of its bio-
chcmi cal nature, th at is associated w ith a no rm al ill1mun o regu-
latory process co uld po tenti all y be empl oyed by neoplastic ce lls 
to a ll ow fo r th eir cmergence and g rowth . Further identifi cat io n 
of th ese imllluno regubtory ci rcuits and the antigens in volved is 
ve ry important fo r a better understandin g o f va ri o us tum o ri genic 
processes th at occur with in the skin. 
Thl' " lIIh",.s ,,,;,<h 1(1 IIIIIII /.: 1?"" " ld A ".~ /;" ji,,. 1,.c1I11;((11 " .15;,<1" ,,(1' " "d ji'" P('l'-
.Ii"'/II;".~ Ih l' SI" ';51;cn l (///(/1)' .1 ;5 ,~r II", daw. 
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